Clinical benefit of complement inhibition has been demonstrated in clinical trials, but there are possible consequences to consider.
Jaclyn L. Kovach, MD
Advertisement
Articles by Jaclyn L. Kovach, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market
2
Eichenbaum Acorns: Collaborative retina care with Jeffry D. Gerson, OD, FAAO
3
NovaBridge, Visara report positive phase 2a results for dual VEGF-A/ANG-2 inhibitor VIS-101
4
Ocugen completes enrollment in liMeliGhT phase 3 trial of OCU400 for retinitis pigmentosa
5